Derik De Bruin Analyst PerformanceManaging Director, Life Sciences Tools & Diagnostics Analyst at Bank of AmericaDerik De Bruin is a stock analyst at Bank of America focused in the medical sector, covering 22 publicly traded companies. Over the past year, Derik De Bruin has issued 13 stock ratings, including buy, hold, and sell recommendations. While full access to Derik De Bruin's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Derik De Bruin's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings51 Last 11 YearsBuy Recommendations47.06% 24 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution51RatingsDistribution of strong buy, buy, hold, and sell ratings by Derik De Bruin.RatingPercentageCount Strong Buy0.0%0 ratings Buy47.1%24 ratings Hold39.2%20 ratings Sell13.7%7 ratingsOut of 51 total stock ratings issued by Derik De Bruin at Bank of America, the majority (47.1%) have been Buy recommendations, followed by 39.2% Hold and 13.7% Sell.Best & Worst CallsBest Call0000.0%EXASAug 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%HOLXJan 2018Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ50.0% of companies on NASDAQ11 companiesNYSE50.0% of companies on NYSE11 companiesDerik De Bruin, an analyst at Bank of America, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical21 companies95.5%Computer and Technology1 company4.5%Derik De Bruin of Bank of America specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE7 companies31.8%MED INSTRUMENTS4 companies18.2%MEDICAL SERVICES3 companies13.6%MED PRODUCTS2 companies9.1%MED/DENTAL - SUPP2 companies9.1%MEDICAL INFO SYS1 company4.5%INSTRU - SCIENTFC1 company4.5%MED - OUTP/HM CRE1 company4.5%MED - GENERIC DRG1 company4.5% Derik De Bruin's Ratings History at Bank of America Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTXG10x Genomics4/20/2026Boost Price Target$25.58$30.00Neutral$0.0000.00% ROIWATWaters2/10/2026Lower Price Target$327.52$350.00Neutral$0.0000.00% ROIBRKRBruker12/15/2025Boost Price Target$45.13$60.00Buy$0.0000.00% ROIAAgilent Technologies11/25/2025Boost Price Target$153.24$165.00Neutral$0.0000.00% ROIMTDMettler-Toledo International9/22/2025Boost Price Target$1,255.78$1,390.00Neutral$0.0000.00% ROIDHRDanaher9/22/2025Lower Price Target$190.91$220.00Buy$0.0000.00% ROIPAHCPhibro Animal Health8/29/2025Boost Price Target$36.88$27.00Underperform$0.0000.00% ROIRVTYRevvity6/26/2025Lower Price Target$98.48$110.00Buy$0.0000.00% ROIBRKRBruker6/26/2025Lower Price Target$41.96$50.00Buy$0.0000.00% ROITXG10x Genomics6/26/2025Boost Price Target$11.43$13.00Neutral$0.0000.00% ROIQGENQiagen6/26/2025Boost Price Target$50.36$55.79Buy$0.0000.00% ROIMTDMettler-Toledo International6/26/2025Boost Price Target$1,189.86$1,260.00Neutral$0.0000.00% ROIWATWaters6/26/2025Boost Price Target$354.15$375.00Neutral$0.0000.00% ROIMYGNMyriad Genetics3/3/2025Lower Price Target$10.73$11.00Underperform$0.0000.00% ROIEXASExact Sciences2/20/2025Lower Price Target$50.48$65.00Buy$000.0000.00% ROINEONeoGenomics2/19/2025Lower Price Target$12.40$16.00Neutral$00.0000.00% ROIWATWaters2/13/2025Lower Price Target$382.45$410.00Neutral$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenMorgan StanleyRoyal Bank Of CanadaBerenberg BankUBS GroupCitigroupBarclaysWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
